Similar Search Results

Do product innovation and news about the R&D process produce large price changes and overreaction? : the case of pharmaceutical stock prices

Pérez Rodríguez, Jorge V.; Valcarcel, Beatriz G. L. - In: Applied economics 44 (2012) 16/18, pp. 2217-2229

Persistent link: https://www.econbiz.de/10009572751

The impact of COVID-19 on stock returns of the Indian healthcare and pharmaceutical sector

Mittal, Shivam; Sharma, Dipasha - In: Australasian accounting business and finance journal : AABF 15 (2021) 1, pp. 5-21

Persistent link: https://www.econbiz.de/10012596763

Early COVID-19 Policy Response on Healthcare Equity Prices

Gurrib, Ikhlaas - 2021

Purpose: This study investigates the implementation of the short selling ban policy imposed by the Italian stock exchange on healthcare stock prices, as a tool to mitigate COVID-19 price effects. Important contributions are in terms of assessing (i) the effect of the temporary short selling ban...

Persistent link: https://www.econbiz.de/10013225474

Short-term stock performance of health care companies in times of viral epidemics and pandemics

Alberti, Eugen; Herberger, Tim; Ender, Manuela - In: Atlantic economic journal : AEJ 51 (2023) 2/3, pp. 131-148

Persistent link: https://www.econbiz.de/10014391986

Competition in the pharmaceutical industry : the case of PAH drugs

Green, Kevin C. - In: International journal of the economics of business 16 (2009) 1, pp. 55-71

Persistent link: https://www.econbiz.de/10003825014

Wealth effects of food and drug administration "Fast Track" designation

Alefantis, Timothy G.; Kulkarni, Mukund S.; Vora, Premal P. - In: Journal of pharmaceutical finance, economics & policy 13 (2004) 3, pp. 41-53

Persistent link: https://www.econbiz.de/10003037568

Pharmaceutical stock price reactions to price constraint threats and firm-level R&D spending

Golec, Joseph; Hedge, Shantaram; Henderson, J. Vernon - 2005

Persistent link: https://www.econbiz.de/10002717615

The economic consequences of US FDA new drug approvals : evidence from Taiwan pharmaceutical and biotech companies

Chen, Yong-Jie; Feng, Zhi-Yuan; Li, Yueh-Ping; Huang, … - In: Innovation: organization & management : IOM 23 (2021) 3, pp. 354-374

Persistent link: https://www.econbiz.de/10012649635

Risk dependence and cointegration between pharmaceutical stock markets : the case of China and the USA

Zhou, Xinmiao; Qian, Huanhuan; Pérez Rodríguez, Jorge V. - In: The North American journal of economics and finance : a … 52 (2020), pp. 1-19

Persistent link: https://www.econbiz.de/10012654918

The signaling effects of incremental information : evidence from stacked US Food and Drug Administration designations

Miller, Kathleen L.; Nardinelli, Clark; Pink, George H.; … - In: The quarterly review of economics and finance : journal … 67 (2018), pp. 219-226

Persistent link: https://www.econbiz.de/10012034461

1
2
3
4
5
6
7
8
9
10
Next
Last